Remark Holdings, INC
Market Movers (8-K)
OTC.Pink
Remark Holdings has issued Series A and Series B preferred stock, and amended its bylaws regarding quorum requirements for stockholder meetings.
OTC.Pink
Remark Holdings has announced the record date and meeting date for its 2024 annual meeting of stockholders, along with revised deadlines for shareholder proposals.
OTC.Pink
Remark Holdings announced a significant 856% sequential revenue increase in Q2 2024 compared to Q1 2024, and a 16.8% year-over-year increase, driven by rapid scaling in North America.
Better than expected
OTC.Pink
Remark Holdings has entered into an exchange agreement with Mudrick Capital Management, L.P., converting existing promissory notes into secured convertible debentures totaling approximately $19.98 million.
Worse than expected
OTC.Pink
Remark Holdings experienced a 50% revenue decrease in Q1 2024 compared to the same period last year, alongside an increased net loss, as the company navigates strategic changes and investments in new markets.
Worse than expected
Delay expected
Capital raise
OTC.Pink
Remark Holdings reported a significant decrease in revenue for fiscal year 2023, primarily due to challenges in China, while also highlighting strategic partnerships and new product launches.
Worse than expected
Capital raise
Quarterly Earnings (10-Q)
OTC.Pink
Remark Holdings reported its Q3 2024 results, highlighting a strategic shift away from China, a significant impairment charge, and ongoing concerns about its ability to continue as a going concern.
Worse than expected
Delay expected
Capital raise
OTC.Pink
Remark Holdings experienced a slight revenue increase in Q2 2024, but ongoing losses and a going concern warning highlight financial challenges.
Worse than expected
Delay expected
Capital raise
OTC.Pink
Remark Holdings reports a net loss of $13.79 million for Q1 2024, facing ongoing financial challenges and strategic shifts.
Worse than expected
Delay expected
Capital raise
Annual Reports (10-K)
OTC.Pink
Remark Holdings has filed an amendment to its 2023 annual report to include information on directors, executive compensation, and corporate governance, which was not included in the original filing.
OTC.Pink
Remark Holdings is navigating delisting from Nasdaq and shifting its business focus away from China due to economic and political challenges.
Delay expected
Capital raise
Worse than expected
Proxy Statements (Def-14A)
OTC.Pink
Remark Holdings cancels its 2023 annual meeting of stockholders due to quorum issues and will proceed directly to the 2024 annual meeting.
New Public Companies (S-1)
OTC.Pink
Remark Holdings, Inc. is set to be delisted from the Nasdaq due to non-compliance with listing rules, with trading expected to move to the OTC Markets system on February 14, 2024.
Worse than expected
Capital raise
OTC.Pink
Remark Holdings has filed an amendment to its Form S-1 registration statement, potentially allowing the resale of up to 20 million shares of its common stock by a selling stockholder.
Worse than expected
Delay expected
Capital raise
OTC.Pink
Remark Holdings has filed a registration statement for the resale of up to 20 million shares of its common stock by a selling stockholder, Ionic Ventures LLC.
Worse than expected
Delay expected
Capital raise